Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03489525
Title MEDI2228 in Subjects With Relapsed/Refractory Multiple Myeloma (MEDI2228)
Acronym MEDI2228
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GRC | ESP | AUS


No variant requirements are available.